In short. The tube, the device, the spin and the interval decide what is injected, and none of it is standardised between clinics.
Key points
- Where a product has no label, the method is the only description of what is being injected.
- That makes the method answerable: a clinic that can describe its tube, its device, its spin and its timing has told you what it is offering, and a clinic that cannot has not.
The preparation step is the least visible part of this treatment and the part that decides what is actually injected. Because there is no product, the process is the specification.
What varies
The tube used, the device that spins it, the speed and duration of the spin, whether a second spin is performed, and the interval between drawing the blood and injecting the material all affect what ends up in the syringe. Protocols differ between clinics on each of these. The consequence is not that one clinic is careless and another careful; it is that two treatments carrying the same name are not the same material, and neither the patient nor an outside clinician can tell from the name alone what was given.
Why this is unusually consequential
For a manufactured injectable, the composition is a condition of the authorisation: the product is tested, defined and released against a specification, and a clinic using it is using the object that was assessed. A point-of-care preparation has none of that structure. What was assessed in a study is one protocol, in one clinic, with one set of equipment. Applying the result to a different protocol is an assumption, and it is usually an unstated one.
The process is the specification
Where a product has no label, the method is the only description of what is being injected. That makes the method answerable: a clinic that can describe its tube, its device, its spin and its timing has told you what it is offering, and a clinic that cannot has not.
Why no standard exists
Standardisation requires somebody to define a specification and to require compliance with it, and for a same-session autologous preparation there is no product to attach that to. Professional guidance exists in places and it is not uniform, and the equipment is regulated as laboratory equipment rather than as a medicine. The absence of a standard is therefore structural rather than an oversight, and it means the variation cannot be resolved by choosing a better-known brand.
What follows for a person considering it
That the question to ask is not which clinic offers the treatment but how the clinic makes it. That a comparison between two clinics is a comparison between two processes. And that a study result quoted at you describes a process, so the useful follow-up question is whether the process described is the process the clinic uses.
Three questions about a preparation
- What equipment and protocol are used, and is that the protocol in the study being cited?
- How long passes between drawing the blood and injecting the material?
- Who performs the preparation, and what training do they have for it?
These are answerable questions about a treatment that has no product label, and the answers describe the treatment more accurately than its name does.
Frequently asked questions
Why does the preparation method matter so much?
Because there is no product behind it. A manufactured injectable arrives with a defined composition that was tested and authorised. A preparation made in the room takes its composition from the tube, the device, the spin and the interval before use, and if those differ between clinics then the injected material differs too.
Is one protocol better than another?
That has not been established. Different protocols produce preparations with different compositions, and the clinical studies describe particular protocols rather than the treatment in general. Without a comparison of protocols against outcomes, there is no basis for saying which is preferable, only for saying they are different.
Does the interval before use matter?
It is one of the variables. A preparation that sits before it is used is not the same material as one used immediately, and the interval is one of the things a clinic can describe. Asking how long it is applied is a reasonable question with an answerable answer.
Risks & Limitations
- The preparation is made in the room and is not standardised, so two clinics offering the same named treatment are not necessarily offering the same material.
- Blood handled outside a controlled laboratory is a medium in which bacteria grow, so preparation carries a risk of infection that the source of the blood does not remove.
- The material is reabsorbed over a short period, so it does not restore volume the way a filler does.
- There is no product authorisation and no approved indication, because there is no manufactured product to authorise.
- Growth factors measured in laboratory work are a finding about the material and not a demonstrated clinical result.
When to Seek Care
- Redness, warmth, swelling or pain that is increasing rather than settling after an injection.
- Discharge from an injection site, or a fever — seek prompt clinical assessment.
- An uneven or lumpy result, or any change in the treated area that concerns you.
- Contact the service that performed the treatment, or the hospital’s outpatient channels, rather than relying on a website.
References & Further Reading
- U.S. Food and Drug Administration (FDA) — guidance on autologous cellular products and point-of-care preparation
- European Medicines Agency (EMA) and national regulators — guidance on blood-derived and autologous treatments
- National Medical Products Administration (NMPA, China) — regulation of blood-derived preparations and devices
- World Health Organization (WHO) — guidance on the safe preparation and handling of blood components
- Cochrane Library — systematic reviews of platelet concentrates for skin and wound indications
This page is patient education, not medical advice, and it does not cite individual studies. It reviews evidence and regulation; it is not a booking page and does not recommend a treatment. Discuss your own case with a qualified clinician. To ask a question about this review, see Contact & Consultation.